Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 822 $ 231
Accounts receivable, net 20,543 19,830
Inventories, net 6,249 6,402
Other current assets 4,842 4,157
Total current assets 32,456 30,620
Medical equipment for sale or rental 4,084 3,049
Medical equipment in rental service, net of accumulated depreciation 34,425 34,928
Property & equipment, net of accumulated depreciation 4,231 4,321
Goodwill 3,710 3,710
Intangible assets, net 7,199 7,446
Operating lease right of use assets 6,206 6,703
Deferred income taxes 9,236 9,115
Derivative financial instruments 1,716 1,442
Other assets 1,587 1,581
Total assets 104,850 102,915
Current liabilities:    
Accounts payable 9,796 8,009
Other current liabilities 7,516 7,704
Total current liabilities 17,312 15,713
Long-term debt, net of current portion 29,931 29,101
Operating lease liabilities, net of current portion 5,331 5,799
Total liabilities 52,574 50,613
Stockholders’ equity:    
Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued 0 0
Common stock, $0.0001 par value: authorized 200,000,000 shares; 21,290,254 shares issued and outstanding as of March 31, 2024 and 21,196,851 shares issued and outstanding as of December 31, 2023 2 2
Additional paid-in capital 110,715 109,837
Accumulated other comprehensive income 1,296 1,088
Retained deficit (59,737) (58,625)
Total stockholders’ equity 52,276 52,302
Total liabilities and stockholders’ equity $ 104,850 $ 102,915